ATE339209T1 - Kombinationstherapie mit gemzitabin und zd6126 - Google Patents

Kombinationstherapie mit gemzitabin und zd6126

Info

Publication number: ATE339209T1
Authority: AT; Austria
Prior art keywords: gemcitabine; human; gemzitabine; combination therapy; warm
Prior art date: 2002-10-09

Application number

AT03758296T

Other languages

English (en)

Inventor

Alan Barge

Original Assignee

Angiogene Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-09

Filing date

2003-10-06

Publication date

2006-10-15

2003-10-06 Application filed by Angiogene Pharm Ltd filed Critical Angiogene Pharm Ltd

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE339209T1 publication Critical patent/ATE339209T1/de

Links

238000002648 combination therapy Methods 0.000 title 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 abstract 5
229960005277 gemcitabine Drugs 0.000 abstract 5
241001465754 Metazoa Species 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 3
238000000034 method Methods 0.000 abstract 3
206010028980 Neoplasm Diseases 0.000 abstract 2
230000000254 damaging effect Effects 0.000 abstract 2
230000005855 radiation Effects 0.000 abstract 2
230000002792 vascular Effects 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 1
239000013066 combination product Substances 0.000 abstract 1
229940127555 combination product Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Iron Core Of Rotating Electric Machines (AREA)

AT03758296T 2002-10-09 2003-10-06 Kombinationstherapie mit gemzitabin und zd6126 ATE339209T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0223379.9A GB0223379D0 (en)	2002-10-09	2002-10-09	Combination therapy

Publications (1)

Publication Number	Publication Date
ATE339209T1 true ATE339209T1 (de)	2006-10-15

Family

ID=9945537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03758296T ATE339209T1 (de)	2002-10-09	2003-10-06	Kombinationstherapie mit gemzitabin und zd6126

Country Status (15)

Country	Link
US (1)	US20060058260A1 (de)
EP (1)	EP1562610B1 (de)
JP (1)	JP2006504722A (de)
KR (1)	KR20050055758A (de)
CN (1)	CN1703225A (de)
AT (1)	ATE339209T1 (de)
AU (1)	AU2003274306B2 (de)
BR (1)	BR0315087A (de)
CA (1)	CA2500906A1 (de)
DE (1)	DE60308403T2 (de)
GB (1)	GB0223379D0 (de)
MX (1)	MXPA05003625A (de)
NO (1)	NO20051601L (de)
WO (1)	WO2004032939A1 (de)
ZA (1)	ZA200502759B (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714249D0 (en) *	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
US6537585B1 (en) *	1999-03-26	2003-03-25	Guilford Pharmaceuticals, Inc.	Methods and compositions for treating solid tumors
US6291504B1 (en) *	1999-10-20	2001-09-18	Dupont Pharmaceuticals Company	Acylsemicarbazides and their uses
ATE298240T1 (de) *	2000-03-31	2005-07-15	Angiogene Pharm Ltd	Getrennte dosis therapien mit gefässschädigender aktivität
EE200200565A (et) *	2000-03-31	2004-06-15	Angiogene Pharmaceuticals Ltd.	Vaskulaarse kahjustava toimega kombinatsioonravi

2002
- 2002-10-09 GB GBGB0223379.9A patent/GB0223379D0/en not_active Ceased
2003
- 2003-10-06 KR KR1020057006138A patent/KR20050055758A/ko not_active Withdrawn
- 2003-10-06 DE DE60308403T patent/DE60308403T2/de not_active Expired - Fee Related
- 2003-10-06 CN CNA2003801011501A patent/CN1703225A/zh active Pending
- 2003-10-06 WO PCT/GB2003/004328 patent/WO2004032939A1/en not_active Ceased
- 2003-10-06 MX MXPA05003625A patent/MXPA05003625A/es not_active Application Discontinuation
- 2003-10-06 EP EP03758296A patent/EP1562610B1/de not_active Expired - Lifetime
- 2003-10-06 JP JP2004542618A patent/JP2006504722A/ja active Pending
- 2003-10-06 BR BR0315087-9A patent/BR0315087A/pt not_active Application Discontinuation
- 2003-10-06 US US10/530,566 patent/US20060058260A1/en not_active Abandoned
- 2003-10-06 AU AU2003274306A patent/AU2003274306B2/en not_active Ceased
- 2003-10-06 AT AT03758296T patent/ATE339209T1/de not_active IP Right Cessation
- 2003-10-06 CA CA002500906A patent/CA2500906A1/en not_active Abandoned
2005
- 2005-03-30 NO NO20051601A patent/NO20051601L/no unknown
- 2005-04-05 ZA ZA200502759A patent/ZA200502759B/en unknown

Also Published As

Publication number	Publication date
JP2006504722A (ja)	2006-02-09
KR20050055758A (ko)	2005-06-13
CN1703225A (zh)	2005-11-30
WO2004032939A1 (en)	2004-04-22
ZA200502759B (en)	2006-06-28
MXPA05003625A (es)	2005-06-03
NO20051601L (no)	2005-04-22
GB0223379D0 (en)	2002-11-13
EP1562610A1 (de)	2005-08-17
EP1562610B1 (de)	2006-09-13
DE60308403D1 (de)	2006-10-26
AU2003274306B2 (en)	2007-02-08
BR0315087A (pt)	2005-08-16
US20060058260A1 (en)	2006-03-16
AU2003274306A1 (en)	2004-05-04
DE60308403T2 (de)	2007-09-06
CA2500906A1 (en)	2004-04-22

Legal Events

Date	Code	Title	Description
2007-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
GB0223380D0 (en)	2002-11-13	Combination therapy
NO20082567L (no)	2008-07-31	Kombinasjon av ZD6474 og pemetrexed
CY1111482T1 (el)	2015-08-05	Συνδυασμος azd2171 και πεμετρεξεδης
MX2007003505A (es)	2007-05-10	Combinacion que comprende zd6474 e imatinib.
NO20056170L (no)	2006-02-08	Kreftkombinasjonsterapi omfattende AZD2171 of ZD1839
NO20064755L (no)	2006-10-20	Kombinasjonsterapi
NO20056171L (no)	2006-02-07	Kombinasjonsterapi
ATE447973T1 (de)	2009-11-15	Kombinationstherapie mit azd-2171
WO2007003933A3 (en)	2007-12-27	Combination therapy of cancer with azd2171 and gemcitabine
ATE339209T1 (de)	2006-10-15	Kombinationstherapie mit gemzitabin und zd6126